Amplia Therapeutics Limited (ASX:ATX)

Australia · Delayed Price · Currency is AUD

0.1200

-0.0050 (-4.00%)

At close: Mar 11, 2026

Revenue by Segment

Financials in millions AUD. Fiscal year is April - March.

Millions AUD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Biopharmaceutical Sector	3.78M	4.45M	1.19M	1.98M	1.53M
Biopharmaceutical Sector Growth	-15.03%	274.34%	-40.03%	29.33%	4380.44%
Total	3.78M	4.45M	1.19M	1.98M	1.53M
Total Growth	-15.03%	274.34%	-40.03%	29.33%	4380.44%

Revenue by Geography

Financials in millions AUD. Fiscal year is April - March.

Millions AUD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Australia	3.78M	4.45M	1.19M	1.98M	1.53M
Australia Growth	-15.03%	274.34%	-40.03%	29.33%	4380.44%
Total	3.78M	4.45M	1.19M	1.98M	1.53M
Total Growth	-15.03%	274.34%	-40.03%	29.33%	4380.44%

Source: S&P Global Market Intelligence.